Frusemide Tablets IP 40 mg
Each uncoated tablet contains Frusemide IP 40 mg.
Furosemide / Frusemide Tablets BP 40 mg
Each uncoated tablet contains Frusemide BP 40 mg.
Usage: Management of oedema, heart failure-related fluid overload and hypertension when indicated.
Category: Diuretic Drugs
Therapeutic Category: Loop Diuretic
SKU: Frusemide Tablets
Categories: Pharmaceutical Exporter India, Pharmaceutical Formulations India, WHO GMP Certified Formulations
Frusemide Tablets is listed in our pharmaceutical product portfolio for business-to-business enquiries. Product-specific formulation details, available strengths, dosage form, pack configuration and supply terms should be confirmed against the current product specification before ordering.
For distributor, wholesaler, hospital procurement and export enquiries, please request the applicable product specifications, batch documentation, shelf-life information, packaging options and regulatory documents. Availability and documentation depend on the product and destination market.
Manufactured by: Healthy Life Pharma Pvt. Ltd. (WHO-GMP Certified)
Exported by: Healthy Inc (Star Export House)
Healthy Life Pharma Pvt. Ltd. manufactures Frusemide Tablets in India. Frusemide, also called furosemide, is a loop diuretic used to manage fluid retention associated with certain heart, liver and kidney conditions, and for selected patients with hypertension. The supplied compositions confirm uncoated 40 mg tablets under IP and BP standards.
| Parameter | Specification |
|---|---|
| Product | Frusemide (Furosemide) Tablets |
| IP formulation | Each uncoated tablet contains Frusemide IP 40 mg |
| BP formulation | Each uncoated tablet contains Frusemide BP 40 mg |
| Strength confirmed | 40 mg (IP and BP) |
| Other strengths mentioned | 20 mg and 500 mg — composition and availability not confirmed |
| Dosage form | Uncoated tablet |
| Therapeutic class | Loop diuretic |
| CAS number | 54-31-9 |
| Packaging / shelf life | Subject to registered product specifications and stability data |
Tablet production requires suitable active-ingredient particle characteristics, validated mixing and compression, and appropriate packaging to meet the registered product specifications. Frusemide has limited water solubility and may be light-sensitive; dissolution and stability must be demonstrated by product-specific testing. No specific micronization process or rapid onset is claimed without supporting manufacturing records.
Quality control can include identity, assay, content uniformity, dissolution, related substances and stability, tested to the applicable IP or BP monograph and approved product specification. Exact dissolution targets, assay ranges and shelf life are product-specific.
Frusemide inhibits the sodium-potassium-chloride cotransporter NKCC2 in the thick ascending limb of the loop of Henle, increasing urinary excretion of sodium, chloride and water. It is used for oedema associated with heart failure, cirrhosis or kidney disorders, and for hypertension when clinically appropriate. It does not treat the underlying cause of kidney failure or reliably restore kidney function. Acute pulmonary oedema may require urgent hospital care and parenteral treatment rather than reliance on an oral tablet.
Product-specific certificates of analysis, dossiers and applicable regulatory documents may be provided subject to availability and destination-market requirements. Strength, packaging, labeling and shelf life must match the approved registration.
Who manufactures Frusemide Tablets?
Healthy Life Pharma Pvt. Ltd., India.
Is frusemide the same active ingredient as furosemide?
Yes. These are alternative spellings of the same active ingredient. Equivalence to any particular branded finished product requires product-specific evidence.
Will urination increase?
Often yes. Timing should follow the prescriber’s instructions to reduce disruption from frequent urination.
Can it lower potassium?
Yes. It can lower potassium and other electrolytes. Monitoring and any supplementation should be directed by a clinician; supplements are not suitable for everyone.
Dosage is individualized according to the condition being treated, kidney function, fluid status, blood pressure and response. Do not use the unconfirmed 20 mg or 500 mg strengths as if supplied. Follow the approved label and prescribing clinician’s directions. Oral dosing may be taken with or without food according to product instructions; avoid changing the dose independently.
Store according to the approved product label, protected from excessive light, heat and moisture. Keep out of reach of children. Do not use tablets showing unexpected deterioration; consult a pharmacist.